Big Move For Alterity Therapeutics Limited

Alterity Therapeutics Limited (ATHE:NASDAQ) jumped higher at $1.11, representing a gain of 33.8%. On Wed, Jan 05, 2022, ATHE:NASDAQ hit a New 2-Week Intraday High of $0.85. The stock appeared on our News Catalysts scanner on Thu, Jan 06, 2022 at 09:54 AM in the 'PRIVATE PLACEMENT' category. From Wed, Dec 22, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days

The stock spiked on Wed, Aug 04, 2021 at $1.82 with a volume of 6B+.

About Alterity Therapeutics Limited (ATHE:NASDAQ)

Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.